12 March 2022>: Lab/In Vitro Research
Downregulated Expression of RIPOR3 Correlated with Immune Infiltrates Predicts Poor Prognosis in Oral Tongue Cancer
Kai Zhang 1BCDE , Junlong Da 1F , Xiaoyao Liu 1F , Xinpeng Liu 1F , Jianqun Wang 1F , Han Jin 1D , Ying Li 1D , Bin Zhang 12AG*DOI: 10.12659/MSM.935055
Med Sci Monit 2022; 28:e935055
Figure 2 Correlations between RIPOR3 mRNA levels with oral squamous cell carcinoma of the mobile tongue (OTSCC) clinical characteristic in the The Cancer Genome Atlas cohort. (A) Stage (stage I&II, n=29; stage III&IV, n=69). (B) Tumor size (T1–2, n=53; T3–4, n=45). (C) Grade (G1, n=17; G2, n=85; G3, n=24). (D) Multivariate Cox analysis of RIPOR3 expression and clinical characteristics in OTSCC (n=98). (* P<0.05, ** P<0.01, *** P<0.001).